Cryo Cell International (CCEL) revenue and earnings history
Cryo Cell International reported revenue of $31.6M for fiscal 2025 (year ended Nov 30, 2025), −1.3% on the year before, and net income of −$2.43M.
Over 15 years, from fiscal 2010 to fiscal 2025, revenue grew at a compound rate of +3.9% a year.
Revenue and net income, 16 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Nov 30, 2025 | $31.6M−1.3% | $482K | −$2.43M | $5.48M | $230K | $5.25M | $417K | $170K | $3.23M | $319K | $8.35M | 10-K |
| 2024ended Nov 30, 2024 |
The latest quarter, insider trades and fund moves: Cryo Cell International (CCEL) on OQRO.
Common questions
What was Cryo Cell International's revenue in fiscal 2025?
$31.6M for the year ended Nov 30, 2025, as reported in its 10-K filed Feb 27, 2026. That is −1.3% on fiscal 2024 ($32M).
How fast has Cryo Cell International's revenue grown?
From $17.8M in fiscal 2010 to $31.6M in fiscal 2025: a compound annual growth rate of +3.9% over 15 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Cryo Cell International tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
